Stillwater Investment Management (Minnesota)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,162
Closed -$202K 62
2017
Q3
$202K Buy
+3,162
New +$185K 0.09% 70
2016
Q3
Sell
-3,467
Closed -$255K 72
2016
Q2
$255K Buy
3,467
+16
+0.5% +$1.13K 0.15% 66
2016
Q1
$220K Buy
3,451
+22
+0.6% +$1.39K 0.13% 69
2015
Q4
$236K Buy
3,429
+19
+0.6% +$1.26K 0.15% 67
2015
Q3
$202K Buy
3,410
+20
+0.6% +$1.27K 0.14% 66
2015
Q2
$226K Buy
3,390
+14
+0.4% +$923 0.14% 65
2015
Q1
$218K Sell
3,376
-18
-0.5% -$1.13K 0.14% 61
2014
Q4
$200K Buy
+3,394
New +$191K 0.13% 62

Other funds holding BMY

Stillwater Investment Management (Minnesota)'s BMY Position: Q4 2017 in Review

Stillwater Investment Management (Minnesota) sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 3,162 shares — an estimated $202K sold.

Stillwater Investment Management (Minnesota) first reported a position in BMY in Q4 2014 and held it in 8 quarters. The position peaked at $255K in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Stillwater Investment Management (Minnesota) reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • Stillwater Investment Management (Minnesota) sold 3,162 Bristol-Myers Squibb shares in Q4 2017, an estimated $202K.
  • Stillwater Investment Management (Minnesota) first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 8 quarters.
  • Stillwater Investment Management (Minnesota)'s Bristol-Myers Squibb position peaked at $255K in Q2 2016.
  • 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Stillwater Investment Management (Minnesota)'s 13F filing for Q4 2017, filed 4 Jan 2018.